Potential use of leukotriene inhibitors in treatment of psoriasis.
Zemtsov
Alexander
A
Bucchino
Svetlana
S
McDowell
Michelle Rene
MR
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007211:Indoles; D020024:Leukotriene Antagonists / Q000008:administration & dosage*; D008875:Middle Aged; D048448:Phenylcarbamates; D011565:Psoriasis / Q000188:drug therapy*; D013449:Sulfonamides; D014105:Tosyl Compounds / Q000008:administration & dosage*
D007211:Indoles; D020024:Leukotriene Antagonists; D048448:Phenylcarbamates; D013449:Sulfonamides; D014105:Tosyl Compounds; C062735:zafirlukast